Crossmark

The cost-effectiveness analysis of semaglutide for the treatment of adult and adolescent patients with overweight and obesity: a systematic review

Published Online: 2024-09-10

Published Print: 2024-12

Authors

Asiabar, Ali Sarabi

Rezaei, Mohammad Ali

Jafarzadeh, Dariush

Rajaei, Soheila

Atefimanesh, Pezhman

Soleimanpour, Samira

Meher, Mohammad Hossein Kafaei

Azari, Samad
License Information

Text and Data Mining valid from 2024-09-10

Version of Record valid from 2024-09-10
More Information

Article History

Received: 3 May 2024

Accepted: 31 August 2024

First Online: 10 September 2024

Declarations

:

: The protocol of this study has been registered with the Code of Ethics IR.IUMS.REC.1402.399 from Iran University of Medical Sciences, which has been conducted at the Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran.

: The authors declare no competing interests.

Document is current